PeptideDB

4,4-Diphenylbutylamine hydrochloride 22101-90-2

4,4-Diphenylbutylamine hydrochloride 22101-90-2

CAS No.: 22101-90-2

The Kis of 4,4-Diphenylbutylamine for 5-HT2A and H1 receptors are 2589 and 1670 nM, respectively.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

The Kis of 4,4-Diphenylbutylamine for 5-HT2A and H1 receptors are 2589 and 1670 nM, respectively.

Physicochemical Properties


Molecular Formula C16H20CLN
Molecular Weight 261.789703369141
Exact Mass 261.128
CAS # 22101-90-2
PubChem CID 140097275
Appearance White to off-white solid powder
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 1
Rotatable Bond Count 5
Heavy Atom Count 18
Complexity 172
Defined Atom Stereocenter Count 0
SMILES

C(C1C=CC=CC=1)(C1C=CC=CC=1)CCCN.Cl

InChi Key MQFLILPZNNSOGK-UHFFFAOYSA-N
InChi Code

InChI=1S/C16H19N.ClH/c17-13-7-12-16(14-8-3-1-4-9-14)15-10-5-2-6-11-15;/h1-6,8-11,16H,7,12-13,17H2;1H
Chemical Name

4,4-diphenylbutan-1-amine;hydrochloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity. Bioorg Med Chem. 2009;17(18):6496-6504.


Solubility Data


Solubility (In Vitro) DMSO: 66.67 mg/mL (254.67 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (9.55 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (9.55 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (9.55 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.8199 mL 19.0993 mL 38.1986 mL
5 mM 0.7640 mL 3.8199 mL 7.6397 mL
10 mM 0.3820 mL 1.9099 mL 3.8199 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.